EpiBiologics

EpiBiologics is a biotech company in San Mateo, United States, founded in 2022. It has raised $264.0M across 3 rounds, most recently a $107.0M Venture Round in January 2026.

Medicines That Matter

Headquarters
San Mateo
Founded
2022
Business Model
B2B
Total Funding
$264.0M
Last Round
$107.0M Venture RoundJan 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

EpiBiologics develops bispecific antibodies designed to selectively degrade disease-causing extracellular proteins. Its EpiTAC platform uses an atlas of more than 270 degradation-inducing protein receptors expressed on distinct tissue and cell types to create tissue-selective therapies against membrane and extracellular proteins. By degrading extracellular targets, the company addresses the portion of the proteome left behind by intracellular degradation approaches, aiming to spare healthy tissue and drive efficacy for cancer, autoimmune disorders, and other serious diseases.

Summary

It has raised $264.0M in total across 3 rounds, most recently a $107.0M Venture Round in Jan 2026. Investors include Polaris Partners, JJDC and Novartis Venture Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundJan 2026
$107.0M

Sign up to see all 3 events

Funding: Series B through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

EpiBiologics on Indexed.vc
<a href="https://indexed.vc/companies/epibiologics"><img src="https://indexed.vc/api/badge/company/epibiologics" alt="EpiBiologics on Indexed.vc" width="260" height="76" /></a>